Expression of the multidrug resistance-a
β
Walter Berger; Leonilla Elbling; Erich Hauptmann; Michael Micksche
π
Article
π
1997
π
John Wiley and Sons
π
French
β 224 KB
π 2 views
Human non-small-cell lung cancer (NSCLC) is considered to be a chemotherapy-refractory malignancy. The underlying mechanisms remain rather obscure. The multidrug resistanceassociated protein (MRP), mediating a multidrug resistance (MDR) phenotype, has been reported to be overexpressed in several dru